84 related articles for article (PubMed ID: 23070602)
21. Effect of squalane on mebendazole-loaded Compritol® nanoparticles.
Graves RA; Ledet GA; Nation CA; Pramar YV; Bostanian LA; Mandal TK
J Biomater Sci Polym Ed; 2015; 26(13):868-80. PubMed ID: 26062393
[TBL] [Abstract][Full Text] [Related]
22. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
Pharm Res; 2014 Feb; 31(2):382-93. PubMed ID: 24022680
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
[TBL] [Abstract][Full Text] [Related]
24. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders.
Waghule T; Rapalli VK; Gorantla S; Saha RN; Dubey SK; Puri A; Singhvi G
Curr Pharm Des; 2020; 26(36):4569-4579. PubMed ID: 32534562
[TBL] [Abstract][Full Text] [Related]
25. Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.
Lin YK; Al-Suwayeh SA; Leu YL; Shen FM; Fang JY
Pharm Res; 2013 Feb; 30(2):435-46. PubMed ID: 23070602
[TBL] [Abstract][Full Text] [Related]
26. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.
Aljuffali IA; Sung CT; Shen FM; Huang CT; Fang JY
AAPS J; 2014 Jan; 16(1):140-50. PubMed ID: 24307611
[TBL] [Abstract][Full Text] [Related]
27. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.
Shamma RN; Aburahma MH
Int J Nanomedicine; 2014; 9():5449-60. PubMed ID: 25473283
[TBL] [Abstract][Full Text] [Related]
28. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery.
Hung CF; Chen WY; Hsu CY; Aljuffali IA; Shih HC; Fang JY
Eur J Pharm Biopharm; 2015 Aug; 94():94-105. PubMed ID: 25986584
[TBL] [Abstract][Full Text] [Related]
31. Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.
Wen CJ; Zhang LW; Al-Suwayeh SA; Yen TC; Fang JY
Int J Nanomedicine; 2012; 7():1599-611. PubMed ID: 22619515
[TBL] [Abstract][Full Text] [Related]
32. Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers for efficient brain targeting.
Liu KS; Wen CJ; Yen TC; Sung KC; Ku MC; Wang JJ; Fang JY
Nanotechnology; 2012 Mar; 23(9):095103. PubMed ID: 22327243
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
[TBL] [Abstract][Full Text] [Related]
34. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
35. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
Desai P; Patlolla RR; Singh M
Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
